✦ LIBER ✦

High-Dose Infusional Gemcitabine Combined with Busulfan and Melphalan with Autologous Stem-Cell Transplantation in Patients with Refractory Lymphoid Malignancies

✍ Scribed by Nieto, Yago; Thall, Peter; Valdez, Ben; Andersson, Borje; Popat, Uday; Anderlini, Paolo; Shpall, Elizabeth J.; Bassett, Roland; Alousi, Amin; Hosing, Chitra; Kebriaei, Partow; Qazilbash, Muzaffar; Frazier, Erin; Gulbis, Alison; Chancoco, Christina; Bashir, Qaiser; Ciurea, Stefan; Khouri, Issa; Parmar, Simrit; Shah, Nina; Worth, Laura; Rondon, Gabriela; Champlin, Richard; Jones, Roy B.

Book ID: 121653196
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 297 KB
Volume: 18
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2012.05.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous Busulfan Plus Melphalan Is a

Intravenous Busulfan Plus Melphalan Is a Highly Effective, Well-Tolerated Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Advanced Lymphoid Malignancies

✍ Partow Kebriaei; Timothy Madden; Reza Kazerooni; Xuemei Wang; Peter F. Thall; Ce 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 232 KB

High-dose melphalan versus busulfan, cyc

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

✍ Don M. Benson Jr.; Patrick J. Elder; Thomas S. Lin; William Blum; Sam Penza; Bel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Comparison of Gemcitabine, Busulfan and

Comparison of Gemcitabine, Busulfan and Melphalan (Gem/Bu/Mel) with Beam and Busulfan/Melphalan (Bu/Mel) in Concurrent Cohorts of Refractory Hodgkin'S Lymphoma (HL) Patients Receiving an Autologous Stem-Cell Transplant

✍ Y. Nieto; R.B. Jones; P. Liu; P. Anderlini; U. Popat; B. Andersson; E.J. Shpall; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB

High Dose Chemotherapy (HDT) with Busulf

High Dose Chemotherapy (HDT) with Busulfan, Melphalan and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Pediatric Patients (pts) with High Risk Solid Tumors

✍ A.B. Pawlowska; J.A. Wolfson; J. Cheng; A. Sorrell; J. Sato; C. Anderson; D. Hit 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 97 KB

High-dose therapy followed by autologous

High-dose therapy followed by autologous bone marrow (BM) transplantation with or without peripheral stem cell (PSC) in patients with lymphoid malignancies

✍ A. Nademanee; G. M. Schmidt; I. Sniecinski; A. C. Dagis; S. J. Forman 📂 Article 📅 1992 🏛 AlphaMed Press 🌐 English ⚖ 121 KB

Comparative pharmacokinetic study of hig

Comparative pharmacokinetic study of high-dose etoposide and etoposide phosphate in patients with lymphoid malignancy receiving autologous stem cell transplantation

✍ Dorr, R T; Briggs, A; Kintzel, P; Meyers, R; Chow, H-HS; List, A 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB